InvestorsHub Logo
Followers 43
Posts 2346
Boards Moderated 0
Alias Born 12/17/2001

Re: Value_Investor post# 2252

Thursday, 04/13/2017 7:11:23 PM

Thursday, April 13, 2017 7:11:23 PM

Post# of 8459
Amazing news in the 10K

In the AtEase study, TNX-102 SL was well tolerated and the patient retention rate was 73% on placebo, 79% on TNX-102 SL 2.8 mg and 84% on TNX-102 SL 5.6 mg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News